{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:11:19Z","timestamp":1783127479626,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["DL57\/2016\/CP1346\/CT0025"],"award-info":[{"award-number":["DL57\/2016\/CP1346\/CT0025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["SFRH\/BD\/146527\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146527\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["PT-OPENSCREEN-NORTE-01-0145-FEDER-085468"],"award-info":[{"award-number":["PT-OPENSCREEN-NORTE-01-0145-FEDER-085468"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["LA\/P\/0056\/2020"],"award-info":[{"award-number":["LA\/P\/0056\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["DL57\/2016\/CP1355\/CT0007"],"award-info":[{"award-number":["DL57\/2016\/CP1355\/CT0007"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.toxrep.2025.101890","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T02:18:04Z","timestamp":1736043484000},"page":"101890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Toxicodynamic insights of 2C and NBOMe drugs \u2013 Is there abuse potential?"],"prefix":"10.1016","volume":"14","author":[{"given":"Eva","family":"Gil-Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-7548","authenticated-orcid":false,"given":"Renata","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.toxrep.2025.101890_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2025.101890_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.toxrep.2025.101890_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxrep.2025.101890_bib4","series-title":"PIHKAL: A Chemical Love Story","author":"Shulgin","year":"1991"},{"issue":"10","key":"10.1016\/j.toxrep.2025.101890_bib5","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.8b00215","article-title":"Dark classics in chemical neuroscience: mescaline","volume":"9","author":"Cassels","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.toxrep.2025.101890_bib6","unstructured":"Heim, R., Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur: Entwicklung eines neuen Struktur-Wirkungskonzepts. 2004."},{"key":"10.1016\/j.toxrep.2025.101890_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnins.2020.00078","article-title":"NBOMes-highly potent and toxic alternatives of LSD","volume":"14","author":"Zawilska","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.toxrep.2025.101890_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2016_64","article-title":"Pharmacology and toxicology of N-Benzylphenethylamine (\"NBOMe\") hallucinogens","volume":"32","author":"Halberstadt","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.toxrep.2025.101890_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12850","article-title":"25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: evidence of abuse potential","volume":"25","author":"Custodio","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.toxrep.2025.101890_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuint.2019.02.007","article-title":"Abuse potential of 2-(4-iodo-2, 5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine (25INBOMe); in vivo and ex vivo approaches","volume":"125","author":"Jeon","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxrep.2025.101890_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2019.07.002","article-title":"A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents","volume":"152","author":"Seo","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.toxrep.2025.101890_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00204-021-02980-x","article-title":"New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents","volume":"95","author":"Kim","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"11","key":"10.1016\/j.toxrep.2025.101890_bib13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/brainsci12111490","article-title":"Rewarding and reinforcing effects of 25H-NBOMe in rodents","volume":"12","author":"Jo","year":"2022","journal-title":"Brain Sci."},{"issue":"15","key":"10.1016\/j.toxrep.2025.101890_bib14","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1021\/acschemneuro.3c00196","article-title":"Designer Drug, 25D-NBOMe, has reinforcing and rewarding effects through change of a dopaminergic neurochemical system","volume":"14","author":"Lee","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.toxrep.2025.101890_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12272-024-01491-4","article-title":"The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents","volume":"47","author":"Kim","year":"2024","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.toxrep.2025.101890_bib16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.toxrep.2025.101890_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.toxrep.2025.101890_bib19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases.","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2025.101890_bib20","first-page":"105","article-title":"Serotonin 2A (5-HT2A) receptor function: ligand-dependent mechanisms and pathways","author":"Raote","year":"2007","journal-title":"Serotonin Recept. Neurobiol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007043482570","article-title":"5-HT1 receptors","volume":"3","author":"Lanfumey","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/ijms25010241","article-title":"Molecular and medical aspects of psychedelics","volume":"25","author":"Wojtas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.101890_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuropharm.2018.02.033","article-title":"Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats","volume":"142","author":"Elmore","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxrep.2025.101890_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcp.2018.09.024","article-title":"Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors","volume":"158","author":"Eshleman","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.101890_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.toxrep.2025.101890_bib26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","author":"Braden","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.toxrep.2025.101890_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2017.07.012","article-title":"Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)","volume":"134","author":"Luethi","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/jpet.106.117507","article-title":"Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors","volume":"321","author":"Moya","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.toxrep.2025.101890_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00213-013-3303-6","article-title":"Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function","volume":"231","author":"Eshleman","year":"2014","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.toxrep.2025.101890_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.bjp.0705722","article-title":"4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes","volume":"141","author":"Villalobos","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.101890_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dta.2494","article-title":"Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases","volume":"11","author":"Wagmann","year":"2019","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.toxrep.2025.101890_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12640-020-00297-8","article-title":"Neurochemical and behavioral effects of a new hallucinogenic compound 25B-NBOMe in rats","volume":"39","author":"Wojtas","year":"2021","journal-title":"Neurotox. Res."},{"issue":"Pt 1","key":"10.1016\/j.toxrep.2025.101890_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","article-title":"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"45","author":"Zwartsen","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.toxrep.2025.101890_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104631","article-title":"Corrigendum to \"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"62","author":"Zwartsen","year":"2020","journal-title":"Toxicol. Vitr."},{"issue":"2","key":"10.1016\/j.toxrep.2025.101890_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcp.2006.09.022","article-title":"Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series)","volume":"73","author":"Theobald","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.101890_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110553","article-title":"In vitro characterization of new psychoactive substances at the mu-opioid, CB1, 5HT1A, and 5-HT2A receptors-On-target receptor potency and efficacy, and off-target effects","volume":"317","author":"\u00c5strand","year":"2020","journal-title":"Forensic Sci. Int."},{"issue":"5","key":"10.1016\/j.toxrep.2025.101890_bib37","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00204-023-03465-9","article-title":"Off-target activity of NBOMes and NBOMe analogs at the micro opioid receptor","volume":"97","author":"Deventer","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00213-005-0009-4","article-title":"Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats","volume":"181","author":"Fantegrossi","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.toxrep.2025.101890_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175926","article-title":"Psychoactive substances 25H-NBOMe and 25H-NBOH induce antidepressant-like behavior in male rats","volume":"955","author":"Ferri","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.101890_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuropharm.2018.10.037","article-title":"Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (\"FLY\") and benzodifuran (\"DragonFLY\") analogs","volume":"144","author":"Halberstadt","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxrep.2025.101890_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","article-title":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response","volume":"77","author":"Halberstadt","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12640-019-00033-x","article-title":"Hallucinogen-like action of the novel designer drug 25I-NBOMe and its effect on cortical neurotransmitters in rats","volume":"36","author":"Herian","year":"2019","journal-title":"Neurotox. Res."},{"issue":"6","key":"10.1016\/j.toxrep.2025.101890_bib43","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s43440-020-00181-4","article-title":"Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission","volume":"72","author":"Herian","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1124\/jpet.114.219337","article-title":"Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice","volume":"351","author":"Smith","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3-4","key":"10.1016\/j.toxrep.2025.101890_bib45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-3057(01)00552-4","article-title":"Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists","volume":"69","author":"Vickers","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.toxrep.2025.101890_bib47","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acschemneuro.0c00129","article-title":"Investigation of the 2,5-dimethoxy motif in phenethylamine serotonin 2A receptor agonists","volume":"11","author":"Marcher-Rorsted","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.toxrep.2025.101890_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-022-06279-2","article-title":"Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines","volume":"240","author":"Halberstadt","year":"2023","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.toxrep.2025.101890_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/FBP.0000000000000309","article-title":"Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents","volume":"28","author":"Gatch","year":"2017","journal-title":"Behav. Pharmacol."},{"issue":"8","key":"10.1016\/j.toxrep.2025.101890_bib51","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00213-021-05860-5","article-title":"Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe","volume":"238","author":"Herian","year":"2021","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1124\/jpet.108.145458","article-title":"Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses","volume":"328","author":"Li","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxrep.2025.101890_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.875722","article-title":"Effect of -NBOMe compounds on sensorimotor, motor, and prepulse inhibition responses in mice in comparison with the 2C analogs and lysergic acid diethylamide: from preclinical evidence to forensic implication in driving under the influence of drugs","volume":"13","author":"Tirri","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.toxrep.2025.101890_bib54","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3389\/fphar.2019.01406","article-title":"Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe","volume":"10","author":"Miliano","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.101890_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109452","article-title":"The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C-NBOMe in male rats","volume":"227","author":"Yu","year":"2023","journal-title":"Neuropharmacology"},{"issue":"3281","key":"10.1016\/j.toxrep.2025.101890_bib56","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1126\/science.126.3281.1020","article-title":"Production of tolerance to psychosis-producing doses of lysergic acid diethylamide","volume":"126","author":"Abramson","year":"1957","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.toxrep.2025.101890_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00005053-195509000-00001","article-title":"Clinical reactions and tolerance to LSD in chronic schizophrenia","volume":"122","author":"Cholden","year":"1955","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.toxrep.2025.101890_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archpsyc.1959.03590030063008","article-title":"and D. Fontanari, Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.","volume":"1","author":"Balestrieri","year":"1959","journal-title":"AMA Arch. Gen. Psychiatry"},{"key":"10.1016\/j.toxrep.2025.101890_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00407974","article-title":"Cross tolerance between LSD and psilocybin","volume":"2","author":"Isbell","year":"1961","journal-title":"Psychopharmacologia"},{"issue":"4","key":"10.1016\/j.toxrep.2025.101890_bib60","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxrep.2025.101890_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/7854_2017_480","article-title":"Interactions of hallucinogens with the glutamatergic system: permissive network effects mediated through cortical layer V pyramidal neurons","volume":"36","author":"Marek","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101890_bib62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0269881116677104","article-title":"The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens","volume":"31","author":"Canal","year":"2017","journal-title":"J. Psychopharmacol."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:43:39Z","timestamp":1778863419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"alternative-id":["S2214750025000010"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.101890","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicodynamic insights of 2C and NBOMe drugs \u2013 Is there abuse potential?","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.101890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101890"}}